Why Weight? The Family Practice Guide for Enhancing the Patient-Provider Connection in Obesity Management

 

 

PROGRAM OVERVIEW

Obesity rates are increasing, and contrary to other major global risks, there is little evidence of successful population-level intervention strategies to reduce rates. As with all chronic medical conditions, effective management of obesity must be based on a partnership between a highly motivated patient and a committed team of clinicians. It is well known that there is a growing shortage of obesity specialists in the United States who diagnose and manage interrelated cardiometabolic disease. Therefore, family practice physicians are expected to become the frontline providers to manage obesity in the near future.

A comprehensive, patient-centered approach to obesity improves patient outcomes, but rarely is implemented. In order for a patient-centered approach to be implemented, clinicians are required to know how to effectively engage their patients and be up-to-date on current medical anti-obesity therapies so they can select the most appropriate agent for their individual patient’s needs. This innovative activity will incorporate multiple evidence-based adult learning principles to improve family physicians’ skills and confidence in weight-loss counseling and treatment.

FACULTY

Deborah Bade Horn, DO, MPH​
Medical Director​
Center for Obesity Medicine and Metabolic Performance​
Clinical Assistant Professor​
Department of Surgery​
University of Texas McGovern Medical School​
Houston, Texas

 

Release date: July 31, 2020
Expiration date: July 31, 2021
Estimated time to complete activity: 0.75 hour(s)

 

TARGET AUDIENCE

This educational initiative has been designed for family practice and primary care providers involved in the management of patients with obesity.

LEARNING OBJECTIVES

Upon completion of this educational activity, participants should be able to:

  • Employ proven communication and counseling strategies to effectively engage patients in weight loss discussion​
  • Examine regional and ethnic disparities to tailor obesity interventions appropriately​
  • Incorporate current practice guidelines and quality indicators to optimize obesity screening, diagnosis, and treatment​
  • Evaluate the efficacy and safety of available and emerging pharmacologic therapies for weight loss and weight maintenance
DIRECTIONS TO LEARNER

There are no fees for participating and receiving CME credit for this activity. During the period of July 31, 2020 through July 31, 2021, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pretest
  • Study the educational activity
  • Complete the posttest and the evaluation form

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better.

MEDIA

Internet

PHYSICIAN CONTINUING MEDICAL EDUCATION ACCREDITATION STATEMENT

Integrity Continuing Education, Inc. is accredited with commendation by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.

CREDIT DESIGNATION

Integrity Continuing Education, Inc. designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CONTACT INFORMATION

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or info@integrityce.com.

DISCLOSURE OF CONFLICTS OF INTEREST

Integrity Continuing Education, Inc. requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education, Inc. for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The following faculty/planners reported the financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Deborah Bade Horn, DO, MPH
Consulting Fees: Gelesis, Medtronic, Novo Nordisk
Speakers’ BureausNovo Nordisk
Contracted Research: Novo Nordisk

Michelle R. Rizzo, ELS, hereby states that she or her spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education, Inc. and Novo Nordisk, Inc. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

PRIVACY POLICY

When you participate in an online educational activity sponsored by Integrity Continuing Education, Inc., you will be asked for your name, degree(s), affiliation(s), street address, telephone number, fax number, and…(continued)

MINIMUM SYSTEM REQUIREMENTS

Windows 98, 2000, XP, 2003, Vista, and 7
Internet Explorer 6/7
Firefox 2
Mozilla 1.7 or higher
Netscape 8.1 or higher
Flash Player 10

Mac OS X 10.3, 10.4
Safari 1.3 (Mac OS 10.3)
Safari 2.0 or higher (Mac OS 10.4)
Firefox 2
Flash Player 10
Use of Internet Explorer browser is not recommended.

Click here for more information on minimum system requirements.

DISCLAIMER

The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

PROVIDER STATEMENT

This activity is provided by Integrity Continuing Education, Inc.

SUPPORTER ACKNOWLEDGEMENT

This activity is supported by an educational grant from Novo Nordisk, Inc.

Continue to Pretest